Strategies for Management of Recurrent Pterygium

NCT02530801 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Pterygium

Interventions

DRUG: Bevacizumab
DRUG: 5 fluorouracil

Sponsor

University of Nottingham